Douglas API - Just another WordPress site

Formation of Clinical Advisory Board for Lead Program R-107

Clinicians China licenced to HTDK Pharmaceuticals

New Zealand’s largest medical R&D facility opens in West Auckland

Trial data suggests major breakthrough in Treatment Resistant Depression

Douglas works with 75 year old inventor to create easy to us spray pump for those with arthritis

Douglas wins Best Large Business in the New Zealand International Business Awards

Douglas Pharmaceutical’s Chief Scientific Officer talks about a new drug for treatment resistant depression

Douglas Pharmaceuticals begins work on $35MM Research and Development building

Douglas Pharmaceuticals tackles treatment-resistant depression

New Zealand children to benefit from $9 million gift to Starship

New Zealand children to benefit from $9 million gift to Starship